Handelsbanken Fonder
WVE icon

Handelsbanken Fonder’s Wave Life Sciences WVE Stock Holding History

Handelsbanken Fonder’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$476K Buy
81,900
+16,400
+25% +$109K ﹤0.01% 1381
2026
Q1 		$475K Buy
65,500
+10,800
+20% +$141K ﹤0.01% 1314
2025
Q4 		$930K Buy
54,700
+3,900
+8% +$39.6K ﹤0.01% 1063
2025
Q3 		$372K Hold
50,800
– – ﹤0.01% 1370
2025
Q2 		$330K Buy
+50,800
New +$335K ﹤0.01% 1398
2025
Q1 		– Sell
-50,800
Closed -$628K – 1544
2024
Q4 		$628K Buy
+50,800
New +$678K ﹤0.01% 1197

Other funds holding WVE

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
APM
a16z Perennial Management Menlo Park, California $1.24B AUM 7.36% 1-Year Est. Return
CCM
Capstone Capital Management Hong Kong $224M AUM
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Handelsbanken Fonder's WVE Position: Q2 2026 in Review

Handelsbanken Fonder increased its Wave Life Sciences (WVE) stake by 25% in Q2 2026, buying an estimated $109K and bringing the position to 81,900 shares worth $476K. The position accounts for ﹤0.01% of the portfolio, ranked #1381.

Handelsbanken Fonder first reported a position in WVE in Q4 2024 and has held it in 6 quarters since. The position peaked at $930K in Q4 2025. 33 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Handelsbanken Fonder held 81,900 shares of Wave Life Sciences worth $476K as of Q2 2026.
  • Handelsbanken Fonder bought 16,400 Wave Life Sciences shares in Q2 2026, an estimated $109K.
  • Wave Life Sciences made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1381 holding.
  • Handelsbanken Fonder first reported a position in Wave Life Sciences in Q4 2024 and has held it in 6 quarters since.
  • Handelsbanken Fonder's Wave Life Sciences position peaked at $930K in Q4 2025.
  • 33 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.